{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:27:59Z","timestamp":1769632079566,"version":"3.49.0"},"reference-count":282,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,28]]},"DOI":"10.7759\/cureus.30788","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T09:19:23Z","timestamp":1666948763000},"source":"Crossref","is-referenced-by-count":2,"title":["A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System"],"prefix":"10.7759","author":[{"given":"Sherine","family":"Abdelmissih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Inflammation in COVID-19: from pathogenesis to treatment","volume":"14","author":"Wong RSY","year":"2021","unstructured":"Wong RSY. Inflammation in COVID-19: from pathogenesis to treatment. Int J Clin Exp Pathol. 2021, 14:831-44.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref2","article-title":"Coronaviruses","author":"Tyrrell DAJ","year":"1996","unstructured":"Tyrrell DAJ, Myint SH. Coronaviruses. Medical Microbiology. 4th Edition. Baron S (ed): University of Texas Medical Branch at Galveston, Galveston, Texas; 1996."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-021-01237-9","article-title":"Neuropsychiatric complications of COVID-19","volume":"23","author":"Nakamura ZM","year":"2021","unstructured":"Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric complications of COVID-19. Curr Psychiatry Rep. 2021, 23:25. 10.1007\/s11920-021-01237-9","journal-title":"Curr Psychiatry Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S373578","article-title":"Post COVID-19 infection psychosis: could SARS-CoV-2 virus infection be a neuropsychiatric condition that triggers psychotic disorders? - A case-based short review","volume":"15","author":"Vasile CI","year":"2022","unstructured":"Vasile CI, Vasile MC, Zlati ML, et al.. Post COVID-19 infection psychosis: could SARS-CoV-2 virus infection be a neuropsychiatric condition that triggers psychotic disorders? - A case-based short review. Infect Drug Resist. 2022, 15:4697-705. 10.2147\/IDR.S373578","journal-title":"Infect Drug Resist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3871","article-title":"Neuropsychiatric complications of COVID-19","volume":"371","author":"Butler M","year":"2020","unstructured":"Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of COVID-19. BMJ. 2020, 371:m3871. 10.1136\/bmj.m3871","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000516258","article-title":"Neurological symptoms, comorbidities, and complications of COVID-19: a literature review and meta-analysis of observational studies","volume":"84","author":"Vakili K","year":"2021","unstructured":"Vakili K, Fathi M, Hajiesmaeili M, et al.. Neurological symptoms, comorbidities, and complications of COVID-19: a literature review and meta-analysis of observational studies. Eur Neurol. 2021, 84:307-24. 10.1159\/000516258","journal-title":"Eur Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00818-7","article-title":"Neurological complications and infection mechanism of SARS-CoV-2","volume":"6","author":"Wan D","year":"2021","unstructured":"Wan D, Du T, Hong W, Chen L, Que H, Lu S, Peng X. Neurological complications and infection mechanism of SARS-CoV-2. Signal Transduct Target Ther. 2021, 6:406. 10.1038\/s41392-021-00818-7","journal-title":"Signal Transduct Target Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221076890","article-title":"Neurological manifestations of long-COVID syndrome: a narrative review","volume":"13","author":"Stefanou MI","year":"2022","unstructured":"Stefanou MI, Palaiodimou L, Bakola E, et al.. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022, 13:10.1177\/20406223221076890","journal-title":"Ther Adv Chronic Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01172-7","article-title":"The aetiology, origins, and diagnosis of severe acute respiratory syndrome","volume":"4","author":"Poon LL","year":"2004","unstructured":"Poon LL, Guan Y, Nicholls JM, Yuen KY, Peiris JS. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis. 2004, 4:663-71. 10.1016\/S1473-3099(04)01172-7","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li W","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, et al.. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003, 426:450-4. 10.1038\/nature02145","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31257","article-title":"MERS-CoV spillover at the camel-human interface","volume":"7","author":"Dudas G","year":"2018","unstructured":"Dudas G, Carvalho LM, Rambaut A, Bedford T. MERS-CoV spillover at the camel-human interface. Elife. 2018, 7:e31257. 10.7554\/eLife.31257","journal-title":"Elife"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0010-9","article-title":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin","volume":"556","author":"Zhou P","year":"2018","unstructured":"Zhou P, Fan H, Lan T, et al.. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature. 2018, 556:255-8. 10.1038\/s41586-018-0010-9","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac045","article-title":"Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA","volume":"23","author":"Bartas M","year":"2022","unstructured":"Bartas M, Volna \u00c1, Beaudoin CA, et al.. Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA. Brief Bioinform. 2022, 23:bbac045. 10.1093\/bib\/bbac045","journal-title":"Brief Bioinform"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-100114-055218","article-title":"Continuous and discontinuous RNA synthesis in coronaviruses","volume":"2","author":"Sola I","year":"2015","unstructured":"Sola I, Almazan F, Zuniga S, Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Annu Rev Virol. 2015, 2:265-88. 10.1146\/annurev-virology-100114-055218","journal-title":"Annu Rev Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.8.6838-6850.1998","article-title":"Coronavirus particle assembly: primary structure requirements of the membrane protein","volume":"72","author":"de Haan CA","year":"1998","unstructured":"de Haan CA, Kuo L, Masters PS, Vennema H, Rottier PJ. Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol. 1998, 72:6838-50. 10.1128\/JVI.72.8.6838-6850.1998","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.022","article-title":"Genotype and phenotype of COVID-19: their roles in pathogenesis","volume":"54","author":"Mousavizadeh L","year":"2021","unstructured":"Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2021, 54:159-63. 10.1016\/j.jmii.2020.03.022","journal-title":"J Microbiol Immunol Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181:271-80.e8. 10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li W","year":"2005","unstructured":"Li W, Zhang C, Sui J, et al.. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005, 24:1634-43. 10.1038\/sj.emboj.7600640","journal-title":"EMBO J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2020-0003","article-title":"Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management","volume":"8","author":"Liu M","year":"2020","unstructured":"Liu M, Wang T, Zhou Y, Zhao Y, Zhang Y, Li J. Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management. J Transl Int Med. 2020, 8:9-19. 10.2478\/jtim-2020-0003","journal-title":"J Transl Int Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp D","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, et al.. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020, 367:1260-3. 10.1126\/science.abb2507","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/2633105520975743","article-title":"The intersection between COVID-19, the gene family of ACE2 and Alzheimer's disease","volume":"15","author":"Haghighi MM","year":"2020","unstructured":"Haghighi MM, Kakhki EG, Sato C, Ghani M, Rogaeva E. The intersection between COVID-19, the gene family of ACE2 and Alzheimer's disease. Neurosci Insights. 2020, 15:10.1177\/2633105520975743","journal-title":"Neurosci Insights"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.04.027","article-title":"Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis","volume":"507","author":"Henry BM","year":"2020","unstructured":"Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020, 507:167-73. 10.1016\/j.cca.2020.04.027","journal-title":"Clin Chim Acta"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.107706","article-title":"Renin: friend or foe?","volume":"93","author":"Brown MJ","year":"2007","unstructured":"Brown MJ. Renin: friend or foe?. Heart. 2007, 93:1026-33. 10.1136\/hrt.2006.107706","journal-title":"Heart"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14105","article-title":"Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1-7)\/MAS receptor axes in human mesangial cells","volume":"7","author":"Stoll D","year":"2019","unstructured":"Stoll D, Yokota R, Sanches Aragao D, Casarini DE. Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1-7)\/MAS receptor axes in human mesangial cells. Physiol Rep. 2019, 7:e14105. 10.14814\/phy2.14105","journal-title":"Physiol Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis C","year":"2012","unstructured":"Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012, 2012:256294. 10.1155\/2012\/256294","journal-title":"Int J Pept"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue M","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, et al.. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000, 87:e1-9. 10.1161\/01.res.87.5.e1","journal-title":"Circ Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona P","year":"2007","unstructured":"Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens. 2007, 21:20-7. 10.1038\/sj.jhh.1002101","journal-title":"J Hum Hypertens"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.006","article-title":"Obesity and outcomes in COVID-19: when an epidemic and pandemic collide","volume":"95","author":"Sanchis-Gomar F","year":"2020","unstructured":"Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. 2020, 95:1445-53. 10.1016\/j.mayocp.2020.05.006","journal-title":"Mayo Clin Proc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the heart","volume":"126","author":"Akhmerov A","year":"2020","unstructured":"Akhmerov A, Marban E. COVID-19 and the heart. Circ Res. 2020, 126:1443-55. 10.1161\/CIRCRESAHA.120.317055","journal-title":"Circ Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-313929","article-title":"Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy","volume":"104","author":"Ramchand J","year":"2018","unstructured":"Ramchand J, Sampaio Rodrigues T, Yudi MB, Burrell LM. Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy. Heart. 2018, 104:1985. 10.1136\/heartjnl-2018-313929","journal-title":"Heart"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.21037\/arh.2019.05.01","article-title":"A translational approach to the renin-angiotensin-aldosterone system in heart failure","volume":"3","author":"Bakogiannis C","year":"2019","unstructured":"Bakogiannis C, Theofilogiannakos E, Papadopoulos C, Lazaridis C, Bikakis I, Tzikas S, Vassilikos V. A translational approach to the renin-angiotensin-aldosterone system in heart failure. Ann Res Hosp. 2019, 3:11. 10.21037\/arh.2019.05.01","journal-title":"Ann Res Hosp"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower MA","year":"2002","unstructured":"Crackower MA, Sarao R, Oudit GY, et al.. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002, 417:822-8. 10.1038\/nature00786","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu H","year":"2016","unstructured":"Gu H, Xie Z, Li T, et al.. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep. 2016, 6:19840. 10.1038\/srep19840","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang P","year":"2014","unstructured":"Yang P, Gu H, Zhao Z, et al.. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014, 4:7027. 10.1038\/srep07027","journal-title":"Sci Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213096","article-title":"Circulating angiotensin peptides levels in acute respiratory distress syndrome correlate with clinical outcomes: a pilot study","volume":"14","author":"Reddy R","year":"2019","unstructured":"Reddy R, Asante I, Liu S, et al.. Circulating angiotensin peptides levels in acute respiratory distress syndrome correlate with clinical outcomes: a pilot study. PLoS One. 2019, 14:e0213096. 10.1371\/journal.pone.0213096","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00759-x","article-title":"A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection","volume":"53","author":"Blume C","year":"2021","unstructured":"Blume C, Jackson CL, Spalluto CM, et al.. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat Genet. 2021, 53:205-14. 10.1038\/s41588-020-00759-x","journal-title":"Nat Genet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-004-0620-6","article-title":"Reading the viral signature by toll-like receptors and other pattern recognition receptors","volume":"83","author":"Mogensen TH","year":"2005","unstructured":"Mogensen TH, Paludan SR. Reading the viral signature by toll-like receptors and other pattern recognition receptors. J Mol Med. 2005, 83:180-92. 10.1007\/s00109-004-0620-6","journal-title":"J Mol Med"},{"key":"ref38","article-title":"Stress and strain in an orthopaedic department on the frontlines during the COVID-19 pandemic: an analysis of burnout and the factors influencing It","volume":"49","author":"Seow JW","year":"2020","unstructured":"Seow JW, Lin S, Khor YP, Hey DH, Kagda FH. Stress and strain in an orthopaedic department on the frontlines during the COVID-19 pandemic: an analysis of burnout and the factors influencing It. Ann Acad Med Singap. 2020, 49:814-6.","journal-title":"Ann Acad Med Singap"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia P","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020, 76:14-20. 10.1016\/j.ejim.2020.04.037","journal-title":"Eur J Intern Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson LA","year":"2020","unstructured":"Henderson LA, Canna SW, Schulert GS, et al.. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020, 72:1059-63. 10.1002\/art.41285","journal-title":"Arthritis Rheumatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen SF","year":"2020","unstructured":"Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020, 130:2202-5. 10.1172\/JCI137647","journal-title":"J Clin Invest"},{"key":"ref42","article-title":"The importance of shedding of membrane proteins for cytokine biology","volume":"11","author":"Mullberg J","year":"2000","unstructured":"Mullberg J, Althoff K, Jostock T, Rose-John S. The importance of shedding of membrane proteins for cytokine biology. Eur Cytokine Netw. 2000, 11:27-38.","journal-title":"Eur Cytokine Netw"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-394447-4.10088-4","article-title":"ADAMs regulate cell-cell interactions by controlling the function of the EGF-receptor, TNF\u03b1 and notch","volume":"1","author":"Blobel CP","year":"2016","unstructured":"Blobel CP. ADAMs regulate cell-cell interactions by controlling the function of the EGF-receptor, TNF\u03b1 and notch. Biomed Sci. 2016, 1:639-49. 10.1016\/B978-0-12-394447-4.10088-4","journal-title":"Biomed Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43839","article-title":"Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessel","volume":"121","author":"Rowlands DJ","year":"2011","unstructured":"Rowlands DJ, Islam MN, Das SR, et al.. Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessel. J Clin Invest. 2011, 121:1986-99. 10.1172\/JCI43839","journal-title":"J Clin Invest"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.536847","article-title":"Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor \u03b1 ectodomain shedding","volume":"289","author":"Schwarz J","year":"2014","unstructured":"Schwarz J, Schmidt S, Will O, et al.. Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor \u03b1 ectodomain shedding. J Biol Chem. 2014, 289:3080-93. 10.1074\/jbc.M113.536847","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90853-4","article-title":"Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence","volume":"184","author":"Upton C","year":"1991","unstructured":"Upton C, Macen JL, Schreiber M, McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 1991, 184:370-82. 10.1016\/0042-6822(91)90853-4","journal-title":"Virology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26139","article-title":"Increasing host cellular receptor\u2014angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection","volume":"92","author":"Zhuang MW","year":"2020","unstructured":"Zhuang MW, Cheng Y, Zhang J, Jiang XM, Wang L, Deng J, Wang PH. Increasing host cellular receptor\u2014angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection. J Med Virol. 2020, 92:2693-701. 10.1002\/jmv.26139","journal-title":"J Med Virol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert DW","year":"2005","unstructured":"Lambert DW, Yarski M, Warner FJ, et al.. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem. 2005, 280:30113-9. 10.1074\/jbc.M505111200","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel VB","year":"2014","unstructured":"Patel VB, Clarke N, Wang Z, et al.. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol. 2014, 66:167-76. 10.1016\/j.yjmcc.2013.11.017","journal-title":"J Mol Cell Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00478.2020","article-title":"Soluble ACE2 as a potential therapy for COVID-19","volume":"320","author":"Krishnamurthy S","year":"2021","unstructured":"Krishnamurthy S, Lockey RF, Kolliputi N. Soluble ACE2 as a potential therapy for COVID-19. Am J Physiol Cell Phsyiol. 2021, 320:C279-81. 10.1152\/ajpcell.00478.2020","journal-title":"Am J Physiol Cell Phsyiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.97","article-title":"Brain protection from stroke with intravenous TNF\u03b1 decoy receptor-trojan horse fusion protein","volume":"32","author":"Sumbria RK","year":"2012","unstructured":"Sumbria RK, Boado RJ, Pardridge WM. Brain protection from stroke with intravenous TNF\u03b1 decoy receptor-trojan horse fusion protein. J Cereb Blood Flow Metab. 2012, 32:1933-8. 10.1038\/jcbfm.2012.97","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref52","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19 - 14 September 2022. Edition 101. (2022). Accessed. September 20, 2022: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---14-september-2022."},{"key":"ref53","unstructured":"Office for National Statistics. Coronavirus (COVID-19) infection survey, UK. 29 July 2022. (2022). Accessed: September 14, 2022: https:\/\/cy.ons.gov.uk\/releases\/coronaviruscovid19infectionsurveyuk29july2022."},{"key":"ref54","unstructured":"Centers for Disease Control and Prevention. Risk for COVID-19 infection, hospitalization, and death by age group. (2022). Accessed. September 21, 2022: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/investigations-discovery\/hospitalization-death-by-age.html."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040129","article-title":"Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis","volume":"10","author":"Abate BB","year":"2022","unstructured":"Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ. 2022, 10:e040129. 10.1136\/bmjopen-2020-040129","journal-title":"BMJ"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1546","article-title":"Covid-19 is an opportunity for gender equality within the workplace and at home","volume":"369","author":"Wenham C","year":"2020","unstructured":"Wenham C, Smith J, Morgan R. Covid-19 is an opportunity for gender equality within the workplace and at home. BMJ. 2020, 369:m1546. 10.1136\/bmj.m1546","journal-title":"BMJ"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14112","article-title":"Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes","volume":"75","author":"Abdelhafiz AH","year":"2021","unstructured":"Abdelhafiz AH, Emmerton D, Sinclair AJ. Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes. Int J Clin Pract. 2021, 75:e14112. 10.1111\/ijcp.14112","journal-title":"Int J Clin Pract"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp065","article-title":"The role of ACE2 in pulmonary diseases\u2014relevance for the nephrologist","volume":"24","author":"Oudit GY","year":"2009","unstructured":"Oudit GY, Imai Y, Kuba K, Scholey JW, Penninger JM. The role of ACE2 in pulmonary diseases\u2014relevance for the nephrologist. Nephrol Dial Transplant. 2009, 24:1362-5. 10.1093\/ndt\/gfp065","journal-title":"Nephrol Dial Transplant"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo T","year":"2020","unstructured":"Guo T, Fan Y, Chen M, et al.. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020, 5:811-8. 10.1001\/jamacardio.2020.1017","journal-title":"JAMA Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30203-0","article-title":"Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic","volume":"7","author":"Rogers JP","year":"2020","unstructured":"Rogers JP, Chesney E, Oliver D, et al.. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020, 7:611-27. 10.1016\/S2215-0366(20)30203-0","journal-title":"Lancet Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102856","article-title":"Latin American authors in the scientific production on depression in times of COVID-19","volume":"65","author":"Hernandez RM","year":"2021","unstructured":"Hernandez RM, Saavedra-Lopez MA, Calle-Ramirez XM. Latin American authors in the scientific production on depression in times of COVID-19. Asian J Psychiatr. 2021, 65:102856. 10.1016\/j.ajp.2021.102856","journal-title":"Asian J Psychiatr"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.03.003","article-title":"Physical activity: a coadjuvant treatment to COVID-19 vaccination?","volume":"94","author":"Valenzuela PL","year":"2021","unstructured":"Valenzuela PL, Simpson RJ, Castillo-Garcia A, Lucia A. Physical activity: a coadjuvant treatment to COVID-19 vaccination?. Brain Behav Immun. 2021, 94:1-3. 10.1016\/j.bbi.2021.03.003","journal-title":"Brain Behav Immun"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19200","article-title":"Neurological symptoms and complications of COVID-19 among patients in a tertiary hospital in Saudi Arabia","volume":"13","author":"Tawakul AA","year":"2021","unstructured":"Tawakul AA, Alharbi AH, Basahal AM, Almalki AM, Alharbi B, Almaghrabi M, Imam A. Neurological symptoms and complications of COVID-19 among patients in a tertiary hospital in Saudi Arabia. Cureus. 2021, 13:e19200. 10.7759\/cureus.19200","journal-title":"Cureus"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3377","article-title":"Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)","volume":"37","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2020, 37:e3377. 10.1002\/dmrr.3377","journal-title":"Diabetes Metab Res Rev"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.10.066","article-title":"Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: implications for COVID-19","volume":"538","author":"Sarver DC","year":"2021","unstructured":"Sarver DC, Wong GW. Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: implications for COVID-19. Biochem Biophys Res Commun. 2021, 538:92-6. 10.1016\/j.bbrc.2020.10.066","journal-title":"Biochem Biophys Res Commun"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.2337\/dbi15-0014","article-title":"Protecting the heart in obesity: role of ACE2 and its partners","volume":"65","author":"Touyz RM","year":"2016","unstructured":"Touyz RM. Protecting the heart in obesity: role of ACE2 and its partners. Diabetes. 2016, 65:19-21. 10.2337\/dbi15-0014","journal-title":"Diabetes"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00311.2019","article-title":"ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue","volume":"317","author":"Kawabe Y","year":"2019","unstructured":"Kawabe Y, Mori J, Morimoto H, et al.. ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue. Am J Physiol Endocrinol Metab. 2019, 317:1140-9. 10.1152\/ajpendo.00311.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1684\/ecn.2018.0415","article-title":"Obesity and inflammation","volume":"29","author":"Karczewski J","year":"2018","unstructured":"Karczewski J, \u015aledzi\u0144ska E, Baturo A, et al.. Obesity and inflammation. Eur Cytokine Netw. 2018, 29:83-94. 10.1684\/ecn.2018.0415","journal-title":"Eur Cytokine Netw"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.08.038","article-title":"Inflammation in obesity-related disease","volume":"145","author":"O\u2019Rourke RW","year":"2009","unstructured":"O\u2019Rourke RW. Inflammation in obesity-related disease. Surgery. 2009, 145:255-9. 10.1016\/j.surg.2008.08.038","journal-title":"Surgery"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor MF","year":"2011","unstructured":"Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011, 29:415-45. 10.1146\/annurev-immunol-031210-101322","journal-title":"Annu Rev Immunol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05209-1","article-title":"Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study","volume":"63","author":"Wang S","year":"2020","unstructured":"Wang S, Ma P, Zhang S, et al.. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020, 63:2102-11. 10.1007\/s00125-020-05209-1","journal-title":"Diabetologia"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox A","year":"2009","unstructured":"Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009, 155:173-81. 10.1111\/j.1365-2249.2008.03860.x","journal-title":"Clin Exp Immunol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0549","article-title":"Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes","volume":"63","author":"Rodriguez-Calvo T","year":"2014","unstructured":"Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes. 2014, 63:3880-90. 10.2337\/db14-0549","journal-title":"Diabetes"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld AL","year":"2014","unstructured":"Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014, 59:713-23. 10.1002\/hep.26672","journal-title":"Hepatology"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng CN","year":"2011","unstructured":"Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011, 121:2111-7. 10.1172\/JCI57132","journal-title":"J Clin Invest"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105244","article-title":"The effects of insulin-like growth factor I and BTP-2 on acute lung injury","volume":"22","author":"Munoz K","year":"2021","unstructured":"Munoz K, Wasnik S, Abdipour A, et al.. The effects of insulin-like growth factor I and BTP-2 on acute lung injury. Int J Mol Sci. 2021, 22:5244. 10.3390\/ijms22105244","journal-title":"Int J Mol Sci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2016.03.002","article-title":"The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients","volume":"29","author":"Suda K","year":"2016","unstructured":"Suda K, Matsumoto R, Fukuoka H, et al.. The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients. Growth Horm IGF Res. 2016, 29:4-10. 10.1016\/j.ghir.2016.03.002","journal-title":"Growth Horm IGF Res"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi M","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, et al.. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020, 126:1456-74. 10.1161\/CIRCRESAHA.120.317015","journal-title":"Circ Res"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1081\/ceh-100100094","article-title":"Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects","volume":"22","author":"Sheu WHH","year":"2000","unstructured":"Sheu WHH, Lee WJ, Chang RL, Chen YT. Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects. Clin Exp Hypertens. 2000, 22:595-606. 10.1081\/ceh-100100094","journal-title":"Clin Exp Hypertens"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802187","article-title":"Tumor necrosis factor \u03b1 and insulin resistance in obese type 2 diabetic patients","volume":"27","author":"Miyazaki Y","year":"2003","unstructured":"Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Tumor necrosis factor \u03b1 and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2003, 27:88-94. 10.1038\/sj.ijo.0802187","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61330","article-title":"Obesity and diabetes as comorbidities for COVID-19: underlying mechanisms and the role of viral-bacterial interactions","volume":"9","author":"Kruglikov IL","year":"2020","unstructured":"Kruglikov IL, Shah M, Scherer PE. Obesity and diabetes as comorbidities for COVID-19: underlying mechanisms and the role of viral-bacterial interactions. Elife. 2020, 9:e61330. 10.7554\/eLife.61330","journal-title":"Elife"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23250","article-title":"Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice","volume":"51","author":"Fiorentino L","year":"2010","unstructured":"Fiorentino L, Vivanti A, Cavalera M, et al.. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology. 2010, 51:103-10. 10.1002\/hep.23250","journal-title":"Hepatology"},{"key":"ref83","unstructured":"Centers for Disease Control and Prevention. Symptoms of COVID-19. (2022). Accessed. September 15, 2022: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"ref84","unstructured":"Mayo Clinic. Coronavirus disease 2019 (COVID-19). (2022). Accessed. September 9, 2022: https:\/\/www.mayoclinic.org\/diseases-conditions\/coronavirus\/symptoms-causes\/syc-20479963."},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02911-9","article-title":"Acute respiratory failure in COVID-19: is it \"typical\" ARDS?","volume":"24","author":"Li X","year":"2020","unstructured":"Li X, Ma X. Acute respiratory failure in COVID-19: is it \"typical\" ARDS?. Crit Care. 2020, 24:198. 10.1186\/s13054-020-02911-9","journal-title":"Crit Care"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li H","year":"2020","unstructured":"Li H, Liu L, Zhang D, et al.. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020, 395:1517-20. 10.1016\/S0140-6736(20)30920-X","journal-title":"Lancet"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"55","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Liang WH, Zhao Y, et al.. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020, 55:2000547. 10.1183\/13993003.00547-2020","journal-title":"Eur Respir J"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-01079-7","article-title":"Central nervous system manifestations associated with COVID-19","volume":"20","author":"Divani AA","year":"2020","unstructured":"Divani AA, Andalib S, Biller J, et al.. Central nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2020, 20:60. 10.1007\/s11910-020-01079-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3390\/v13122540","article-title":"Coronavirus RNA synthesis takes place within membrane-bound sites","volume":"13","author":"Doyle N","year":"2021","unstructured":"Doyle N, Simpson J, Hawes PC, Maier HJ. Coronavirus RNA synthesis takes place within membrane-bound sites. Viruses. 2021, 13:2540. 10.3390\/v13122540","journal-title":"Viruses"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.384","article-title":"Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up","volume":"169","author":"Lam MH","year":"2009","unstructured":"Lam MH, Wing YK, Yu MW, et al.. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009, 169:2142-7. 10.1001\/archinternmed.2009.384","journal-title":"Arch Intern Med"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51496","article-title":"Long COVID-19: objectifying most self-reported neurological symptoms","volume":"9","author":"Bungenberg J","year":"2022","unstructured":"Bungenberg J, Humkamp K, Hohenfeld C, et al.. Long COVID-19: objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol. 2022, 9:141-54. 10.1002\/acn3.51496","journal-title":"Ann Clin Transl Neurol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.12.013","article-title":"Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation","volume":"58","author":"DeCarolis NA","year":"2010","unstructured":"DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacol. 2010, 58:884-93. 10.1016\/j.neuropharm.2009.12.013","journal-title":"Neuropharmacol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.315","article-title":"Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration","volume":"37","author":"Recinto P","year":"2012","unstructured":"Recinto P, Samant AR, Chavez G, et al.. Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration. Neuropsychopharmacol. 2012, 37:1275-87. 10.1038\/npp.2011.315","journal-title":"Neuropsychopharmacol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/BF01462293","article-title":"Immunocytochemical evaluation of the blood-brain barrier to endogenous albumin in the olfactory bulb and pons of senescence-accelerated mice (SAM)","volume":"105","author":"Ueno M","year":"1996","unstructured":"Ueno M, Dobrogowska DH, Vorbrodt AW. Immunocytochemical evaluation of the blood-brain barrier to endogenous albumin in the olfactory bulb and pons of senescence-accelerated mice (SAM). Histochem Cell Biol. 1996, 105:203-12. 10.1007\/BF01462293","journal-title":"Histochem Cell Biol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1177\/1073858420956905","article-title":"Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection","volume":"27","author":"Butowt R","year":"2021","unstructured":"Butowt R, von Bartheld CS. Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist. 2021, 27:582-603. 10.1177\/1073858420956905","journal-title":"Neuroscientist"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.01.024","article-title":"The role of gut-brain axis in SARA-CoV-2 neuroinvasion: culprit or innocent bystander?","volume":"94","author":"Shi Y","year":"2021","unstructured":"Shi Y, Li Z, Yang C, Liu C. The role of gut-brain axis in SARA-CoV-2 neuroinvasion: culprit or innocent bystander?. Brain Behav Immun. 2021, 94:476-7. 10.1016\/j.bbi.2021.01.024","journal-title":"Brain Behav Immun"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini A","year":"2020","unstructured":"Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020, 16:636-44. 10.1038\/s41582-020-0398-3","journal-title":"Nat Rev Neurol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges M","year":"2019","unstructured":"Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dub\u00e9 M, Talbot PJ. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?. Viruses. 2019, 12:14. 10.3390\/v12010014","journal-title":"Viruses"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577453","article-title":"Putative mechanisms explaining neuro-COVID","volume":"350","author":"Finsterer J","year":"2020","unstructured":"Finsterer J. Putative mechanisms explaining neuro-COVID. J Neuroimmunol. 2020, 350:577453. 10.1016\/j.jneuroim.2020.577453","journal-title":"J Neuroimmunol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00335","article-title":"ACE\/ACE2 ratio: a key also in 2019 coronavirus disease (Covid-19)?","volume":"7","author":"Pagliaro P","year":"2020","unstructured":"Pagliaro P, Penna C. ACE\/ACE2 ratio: a key also in 2019 coronavirus disease (Covid-19)?. Front Med (Lausanne). 2020, 7:335. 10.3389\/fmed.2020.00335","journal-title":"Front Med (Lausanne)"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease","volume":"139","author":"Evans CE","year":"2020","unstructured":"Evans CE, Miners JS, Piva G, et al.. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease. Acta Neuropathol. 2020, 139:485-502. 10.1007\/s00401-019-02098-6","journal-title":"Acta Neuropathol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx083","article-title":"Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms","volume":"21","author":"Borsini A","year":"2018","unstructured":"Borsini A, Cattaneo A, Malpighi C, et al.. Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms. Int J Neuropsychopharmacol. 2018, 21:187-200. 10.1093\/ijnp\/pyx083","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-020-02554-1","article-title":"COVID-19-induced anosmia associated with olfactory bulb atrophy","volume":"63","author":"Chiu A","year":"2021","unstructured":"Chiu A, Fischbein N, Wintermark M, Zaharchuk G, Yun PT, Zeineh M. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021, 63:147-8. 10.1007\/s00234-020-02554-1","journal-title":"Neuroradiology"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bjq028","article-title":"Anosmia leads to a loss of gray matter in cortical brain areas","volume":"35","author":"Bitter T","year":"2010","unstructured":"Bitter T, Gudziol H, Burmeister HP, Mentzel HJ, Guntinas-Lichius, Gaser C. Anosmia leads to a loss of gray matter in cortical brain areas. Chem Senses. 2010, 35:407-15. 10.1093\/chemse\/bjq028","journal-title":"Chem Senses"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27045","article-title":"Brain volume changes in hyposmic patients before and after olfactory training","volume":"128","author":"Gellrich J","year":"2018","unstructured":"Gellrich J, Han P, Manesse C, et al.. Brain volume changes in hyposmic patients before and after olfactory training. Laryngoscope. 2018, 128:1531-6. 10.1002\/lary.27045","journal-title":"Laryngoscope"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-017-9817-5","article-title":"Congenital olfactory impairment is linked to cortical changes in prefrontal and limbic brain regions","volume":"12","author":"Karstensen HG","year":"2018","unstructured":"Karstensen HG, Vestergaard M, Baare WFC, et al.. Congenital olfactory impairment is linked to cortical changes in prefrontal and limbic brain regions. Brain Imaging Behav. 2018, 12:1569-82. 10.1007\/s11682-017-9817-5","journal-title":"Brain Imaging Behav"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bjs059","article-title":"Olfaction under metabolic influences","volume":"37","author":"Palouzier-Paulignan B","year":"2012","unstructured":"Palouzier-Paulignan B, Lacroix MC, Aime P, et al.. Olfaction under metabolic influences. Chem Senses. 2012, 37:769-97. 10.1093\/chemse\/bjs059","journal-title":"Chem Senses"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/s0196-9781(99)00157-6","article-title":"Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord","volume":"20","author":"Cutler DJ","year":"1999","unstructured":"Cutler DJ, Morris R, Sheridhar V, et al.. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides. 1999, 20:1455-70. 10.1016\/s0196-9781(99)00157-6","journal-title":"Peptides"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(02)03755-1","article-title":"Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally","volume":"960","author":"Caillol M","year":"2003","unstructured":"Caillol M, Aioun J, Baly C, Persuy MA, Salesse R. Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally. Brain Res. 2003, 960:48-61. 10.1016\/s0006-8993(02)03755-1","journal-title":"Brain Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(00)81041-7","article-title":"Orexin synthesis and response in the gut","volume":"24","author":"Kirchgessner AL","year":"1999","unstructured":"Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron. 1999, 24:941-51. 10.1016\/s0896-6273(00)81041-7","journal-title":"Neuron"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.699582","article-title":"Cognitive impairment after COVID-19\u2014A review on objective test data","volume":"12","author":"Daroische R","year":"2021","unstructured":"Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19\u2014A review on objective test data. Front Neurol. 2021, 12:1238. 10.3389\/fneur.2021.699582","journal-title":"Front Neurol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006919","article-title":"Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain","volume":"92","author":"Dintica CS","year":"2019","unstructured":"Dintica CS, Marseglia A, Rizzuto D, et al.. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology. 2019, 92:700-9. 10.1212\/WNL.0000000000006919","journal-title":"Neurology"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13626","article-title":"Olfactory training for olfactory dysfunction in COVID-19: a promising mitigation amidst looming neurocognitive sequelae of the pandemic","volume":"49","author":"Ojho P","year":"2021","unstructured":"Ojho P, Dixit A. Olfactory training for olfactory dysfunction in COVID-19: a promising mitigation amidst looming neurocognitive sequelae of the pandemic. Clin Exp Pharmacol Physiol. 2021, 49:462-73. 10.1111\/1440-1681.13626","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2013.256271","article-title":"Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats","volume":"591","author":"Li A","year":"2013","unstructured":"Li A, Hindmarch CC, Nattie EE, Paton JF. Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats. J Physiol. 2013, 591:4237-48. 10.1113\/jphysiol.2013.256271","journal-title":"J Physiol"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.23.1.0454","article-title":"Orexins in the brain-gut axis","volume":"23","author":"Kirchgessner AL","year":"2002","unstructured":"Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002, 23:1-15. 10.1210\/edrv.23.1.0454","journal-title":"Endocr Rev"},{"key":"ref116","article-title":"Central and local (enteric) action of orexins","volume":"57","author":"Korczynski W","year":"2006","unstructured":"Korczynski W, Ceregrzyn M, Matyjek R, Kato I, Kuwahara A, Wolinski J, Zabielski R. Central and local (enteric) action of orexins. J Physiol Pharmacol. 2006, 57:17-42.","journal-title":"J Physiol Pharmacol"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell TE","year":"2011","unstructured":"Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2011, 51:243-66. 10.1146\/annurev-pharmtox-010510-100528","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai T","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, et al.. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998, 92:573-85. 10.1016\/s0092-8674(00)80949-6","journal-title":"Cell"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00220","article-title":"The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases","volume":"11","author":"Wang C","year":"2018","unstructured":"Wang C, Wang Q, Ji B, et al.. The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases. Front Mol Neurosci. 2018, 11:220. 10.3389\/fnmol.2018.00220","journal-title":"Front Mol Neurosci"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2012.00044","article-title":"Hypothalamus-olfactory system crosstalk: orexin A immunostaining in mice","volume":"6","author":"Gascuel J","year":"2012","unstructured":"Gascuel J, Lemoine A, Rigault C, Datiche F, Benani A, Penicaud L, Lopez-Mascaraque L. Hypothalamus-olfactory system crosstalk: orexin A immunostaining in mice. Front Neuroanat. 2012, 6:44. 10.3389\/fnana.2012.00044","journal-title":"Front Neuroanat"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2011.01.001","article-title":"Orexins and their receptors from fish to mammals: a comparative approach","volume":"171","author":"Wong KKY","year":"2011","unstructured":"Wong KKY, Ng SYL, Lee LTO, Ng HKH, Chow BKC. Orexins and their receptors from fish to mammals: a comparative approach. General Comparative Endocrinol. 2011, 171:124-30. 10.1016\/j.ygcen.2011.01.001","journal-title":"General Comparative Endocrinol"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-009-9433-z","article-title":"Orexin-A and orexin-B during the postnatal development of the rat brain","volume":"30","author":"Stoyanova IL","year":"2010","unstructured":"Stoyanova IL, Rutten WLC, le Feber J. Orexin-A and orexin-B during the postnatal development of the rat brain. Cell Mol Neurobiol. 2010, 30:81-9. 10.1007\/s10571-009-9433-z","journal-title":"Cell Mol Neurobiol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2004.02.007","article-title":"Comparison of hypocretin\/orexin and melanin-concentrating hormone neurons and axonal projections in the embryonic and postnatal rat brain","volume":"27","author":"Steininger TL","year":"2004","unstructured":"Steininger TL, Kilduff TS, Behan M, Benca RM, Landry CF. Comparison of hypocretin\/orexin and melanin-concentrating hormone neurons and axonal projections in the embryonic and postnatal rat brain. J Chem Neuroanat. 2004, 27:165-81. 10.1016\/j.jchemneu.2004.02.007","journal-title":"J Chem Neuroanat"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1002\/cne.10860","article-title":"Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2","volume":"465","author":"Rosin DL","year":"2003","unstructured":"Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol. 2003, 465:593-603. 10.1002\/cne.10860","journal-title":"J Comp Neurol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","article-title":"Orexin (hypocretin) neurons contain dynorphin","volume":"21","author":"Chou TC","year":"2001","unstructured":"Chou TC, Lee CE, Lu J, et al.. Orexin (hypocretin) neurons contain dynorphin. J Neurosci. 2001, 21:RC168. 10.1523\/JNEUROSCI.21-19-j0003.2001","journal-title":"J Neurosci"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"De Lecea L","year":"1998","unstructured":"De Lecea L, Kilduff TS, Peyron C, et al.. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998, 95:322-7. 10.1073\/pnas.95.1.322","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.429","article-title":"To eat or to sleep? Orexin in the regulation of feeding and wakefulness","volume":"24","author":"Willie JT","year":"2001","unstructured":"Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci. 2001, 24:429-58. 10.1146\/annurev.neuro.24.1.429","journal-title":"Annu Rev Neurosci"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.048025","article-title":"Distinct recognition of OX1 and OX2 receptors by orexin peptides","volume":"305","author":"Ammoun S","year":"2003","unstructured":"Ammoun S, Holmqvist T, Shariatmadari R, et al.. Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther. 2003, 305:507-14. 10.1124\/jpet.102.048025","journal-title":"J Pharmacol Exp Ther"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao L","year":"2020","unstructured":"Mao L, Jin H, Wang M, et al.. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77:683-90. 10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.032","article-title":"Inflammatory bowel diseases and COVID-19: the invisible enemy","volume":"158","author":"D'Amico F","year":"2020","unstructured":"D'Amico F, Peyrin-Biroulet L, Danese S. Inflammatory bowel diseases and COVID-19: the invisible enemy. Gastroentrology. 2020, 158:2302-4. 10.1053\/j.gastro.2020.04.032","journal-title":"Gastroentrology"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101123","article-title":"ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - role of gut microbiota dysbiosis","volume":"62","author":"Viana SD","year":"2020","unstructured":"Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - role of gut microbiota dysbiosis. Ageing Res Rev. 2020, 62:101123. 10.1016\/j.arr.2020.101123","journal-title":"Ageing Res Rev"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto T","year":"2012","unstructured":"Hashimoto T, Perlot T, Rehman A, et al.. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012, 487:477-81. 10.1038\/nature11228","journal-title":"Nature"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.074","article-title":"Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis","volume":"15","author":"M\u00f6hle L","year":"2016","unstructured":"M\u00f6hle L, Mattei D, Heimesaat MM, et al.. Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep. 2016, 15:1945-56. 10.1016\/j.celrep.2016.04.074","journal-title":"Cell Rep"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24476","article-title":"The role of inflammation and the gut microbiome in depression and anxiety","volume":"97","author":"Pierce JM","year":"2019","unstructured":"Pierce JM, Alvina K. The role of inflammation and the gut microbiome in depression and anxiety. J Neurosci Res. 2019, 97:1223-41. 10.1002\/jnr.24476","journal-title":"J Neurosci Res"},{"key":"ref135","article-title":"Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism","volume":"58","author":"Zwirska-Korczala K","year":"2007","unstructured":"Zwirska-Korczala K, Adamczyk-Sowa M, Sowa P, et al.. Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. J Physiol Pharmacol. 2007, 58:53-64.","journal-title":"J Physiol Pharmacol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.2009.02035.x","article-title":"Orexins\/hypocretins and orexin receptors in apoptosis: a mini-review","volume":"198","author":"Laburthe M","year":"2010","unstructured":"Laburthe M, Voisin T, El Firar A. Orexins\/hypocretins and orexin receptors in apoptosis: a mini-review. Acta Physiol (Oxf). 2010, 198:393-402. 10.1111\/j.1748-1716.2009.02035.x","journal-title":"Acta Physiol (Oxf)"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.1.6396","article-title":"Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain","volume":"140","author":"Shenoy UV","year":"1999","unstructured":"Shenoy UV, Richards EM, Huang XC, Sumners C. Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology. 1999, 140:500-9. 10.1210\/endo.140.1.6396","journal-title":"Endocrinology"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg JE","year":"2000","unstructured":"Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000, 20:9104-10. 10.1523\/JNEUROSCI.20-24-09104.2000","journal-title":"J Neurosci"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2015.06.010","article-title":"Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2\/ROS and PI3K\/NO pathways","volume":"336","author":"Xiao X","year":"2015","unstructured":"Xiao X, Zhang C, Ma X, et al.. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2\/ROS and PI3K\/NO pathways. Exp Cell Res. 2015, 336:58-65. 10.1016\/j.yexcr.2015.06.010","journal-title":"Exp Cell Res"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1890","article-title":"Orexin A suppresses oxidized LDL induced endothelial cell inflammation via MAPK p38 and NF-\u03baB signaling pathway","volume":"70","author":"Zhang H","year":"2018","unstructured":"Zhang H, Liang B, Li T, Zhou Y, Shang D, Du Z. Orexin A suppresses oxidized LDL induced endothelial cell inflammation via MAPK p38 and NF-\u03baB signaling pathway. IUBMB Life. 2018, 70:961-8. 10.1002\/iub.1890","journal-title":"IUBMB Life"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.08.023","article-title":"Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A","volume":"1864","author":"Messal N","year":"2018","unstructured":"Messal N, Fernandez N, Dayot S, et al.. Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A. Biochem Biophys Acta Mol Basis Dis. 2018, 1864:3618-28. 10.1016\/j.bbadis.2018.08.023","journal-title":"Biochem Biophys Acta Mol Basis Dis"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200547","article-title":"Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin 6 through STAT3 signaling in synovial tissues","volume":"47","author":"Mokuda S","year":"2020","unstructured":"Mokuda S, Tokunaga T, Masumoto J, Sugiyama E. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin 6 through STAT3 signaling in synovial tissues. J Rheumatol. 2020, 47:1593-5. 10.3899\/jrheum.200547","journal-title":"J Rheumatol"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.07.159","article-title":"Orexin A may suppress inflammatory response in fibroblast-like synoviocytes","volume":"107","author":"Sun M","year":"2018","unstructured":"Sun M, Wang W, Li Q, Yuan T, Weng W. Orexin A may suppress inflammatory response in fibroblast-like synoviocytes. Biomed Pharmacother. 2018, 107:763-8. 10.1016\/j.biopha.2018.07.159","journal-title":"Biomed Pharmacother"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14566","article-title":"Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour","volume":"23","author":"Zhan S","year":"2019","unstructured":"Zhan S, Che P, Zhao XK, et al.. Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour. J Cell Mol Med. 2019, 23:6822-34. 10.1111\/jcmm.14566","journal-title":"J Cell Mol Med"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i44.7582","article-title":"Orexins: a promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions","volume":"27","author":"Couniveau A","year":"2021","unstructured":"Couniveau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: a promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol. 2021, 27:7582-96. 10.3748\/wjg.v27.i44.7582","journal-title":"World J Gastroenterol"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus DC","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013, 369:840-51. 10.1056\/NEJMra1208623","journal-title":"N Engl J Med"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2020-0014","article-title":"Detection of early cytokine storm in patients with septic shock after abdominal surgery","volume":"8","author":"Chao J","year":"2020","unstructured":"Chao J, Cui S, Liu C, et al.. Detection of early cytokine storm in patients with septic shock after abdominal surgery. J Transl Int Med. 2020, 8:91-8. 10.2478\/jtim-2020-0014","journal-title":"J Transl Int Med"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0802-3","article-title":"Angiotensin II in septic shock","volume":"19","author":"Corr\u00eaa TD","year":"2015","unstructured":"Corr\u00eaa TD, Takala J, Jakob SM. Angiotensin II in septic shock. Crit Care. 2015, 19:98. 10.1186\/s13054-015-0802-3","journal-title":"Crit Care"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai Y","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, et al.. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005, 436:112-6. 10.1038\/nature03712","journal-title":"Nature"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828e9843","article-title":"Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis","volume":"41","author":"Deutschman CS","year":"2013","unstructured":"Deutschman CS, Raj NR, McGuire EO, Kelz MB. Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med. 2013, 41:368-75. 10.1097\/CCM.0b013e31828e9843","journal-title":"Crit Care Med"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21055","article-title":"Peripherally administered orexin improves survival of mice with endotoxin shock","volume":"5","author":"Ogawa Y","year":"2016","unstructured":"Ogawa Y, Irukayama-Tomobe Y, Murakoshi N, et al.. Peripherally administered orexin improves survival of mice with endotoxin shock. Elife. 2016, 5:e21055. 10.7554\/eLife.21055","journal-title":"Elife"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.11.001","article-title":"Sleep disorders, obesity, and aging: the role of orexin","volume":"20","author":"Nixon JP","year":"2015","unstructured":"Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev. 2015, 20:63-73. 10.1016\/j.arr.2014.11.001","journal-title":"Ageing Res Rev"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.07.019","article-title":"GABA(A) receptors mediate orexin-A induced stimulation of food intake","volume":"50","author":"Kokare DM","year":"2006","unstructured":"Kokare DM, Patole AM, Carta A, Chopde CT, Subhedar NK. GABA(A) receptors mediate orexin-A induced stimulation of food intake. Neuropharmacol. 2006, 50:16-24. 10.1016\/j.neuropharm.2005.07.019","journal-title":"Neuropharmacol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249368","article-title":"Unraveling the role of leptin in liver function and its relationship with liver diseases","volume":"21","author":"Martinez-Una M","year":"2020","unstructured":"Martinez-Una M, Lopez-Mancheno Y, Dieguez C, Fernandez-Rojo MA, Novelle MG. Unraveling the role of leptin in liver function and its relationship with liver diseases. Int J Mol Sci. 2020, 21:9368. 10.3390\/ijms21249368","journal-title":"Int J Mol Sci"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1016\/s0143-4179(02)00085-9","article-title":"Orexins and appetite regulation","volume":"36","author":"Rodgers RJ","year":"2002","unstructured":"Rodgers RJ, Ishii Y, Halford JC, Blundell JE. Orexins and appetite regulation. Neuropeptides. 2002, 36:303-25. 10.1016\/s0143-4179(02)00085-9","journal-title":"Neuropeptides"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-0115(00)00203-2","article-title":"Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats","volume":"96","author":"Rodgers RJ","year":"2000","unstructured":"Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Blundell JE. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept. 2000, 96:71-84. 10.1016\/s0167-0115(00)00203-2","journal-title":"Regul Pept"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(99)01905-8","article-title":"Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight","volume":"849","author":"Yamanaka A","year":"1999","unstructured":"Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res. 1999, 849:248-52. 10.1016\/s0006-8993(99)01905-8","journal-title":"Brain Res"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(03)00331-3","article-title":"Hypothalamic orexin neurons regulate arousal according to energy balance in mice","volume":"38","author":"Yamanaka A","year":"2003","unstructured":"Yamanaka A, Beuckmann CT, Willie JT, et al.. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 2003, 38:701-13. 10.1016\/s0896-6273(03)00331-3","journal-title":"Neuron"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.01.046","article-title":"Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions","volume":"380","author":"Hara J","year":"2005","unstructured":"Hara J, Yanagisawa M, Sakurai T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci Lett. 2005, 380:239-42. 10.1016\/j.neulet.2005.01.046","journal-title":"Neurosci Lett"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1080\/00071669987115","article-title":"Intracerebroventricular injection of orexins does not stimulate food intake in neonatal chicks","volume":"40","author":"Furuse M","year":"1999","unstructured":"Furuse M, Ando R, Bungo T, Ao R, Shimojo M, Masuda Y. Intracerebroventricular injection of orexins does not stimulate food intake in neonatal chicks. Br Poult Sci. 1999, 40:698-700. 10.1080\/00071669987115","journal-title":"Br Poult Sci"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2004.07.018","article-title":"Food intake in rhesus monkeys following central administration of orexins","volume":"124","author":"Ramsey JJ","year":"2005","unstructured":"Ramsey JJ, Kemnitz JW, Newton W, Hagopian K, Patterson TA, Swick AG. Food intake in rhesus monkeys following central administration of orexins. Regul Pept. 2005, 124:209-14. 10.1016\/j.regpep.2004.07.018","journal-title":"Regul Pept"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00218.2004","article-title":"Orexin-A does not stimulate food intake in old rats","volume":"287","author":"Takano S","year":"2004","unstructured":"Takano S, Kanai S, Hosoya H, Ohta M, Uematsu H, Miyasaka K. Orexin-A does not stimulate food intake in old rats. Am J Physiol Gastrointest Liver Physiol. 2004, 287:1182-7. 10.1152\/ajpgi.00218.2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.2001.00719.x","article-title":"Evidence that orexin-containing neurones provide direct input to gonadotropin-releasing hormone neurones in the ovine hypothalamus","volume":"13","author":"Iqbal J","year":"2001","unstructured":"Iqbal J, Pompolo S, Sakurai T, Clarke IJ. Evidence that orexin-containing neurones provide direct input to gonadotropin-releasing hormone neurones in the ovine hypothalamus. J Neuroendocrinol. 2001, 13:1033-41. 10.1046\/j.1365-2826.2001.00719.x","journal-title":"J Neuroendocrinol"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2013.254086","article-title":"Glucose sensitivity of mouse olfactory bulb neurons is conveyed by a voltage-gated potassium channel","volume":"591","author":"Tucker K","year":"2013","unstructured":"Tucker K, Cho S, Thiebaud N, Henderson MX, Fadool DA. Glucose sensitivity of mouse olfactory bulb neurons is conveyed by a voltage-gated potassium channel. J Physiol. 2013, 591:2541-61. 10.1113\/jphysiol.2013.254086","journal-title":"J Physiol"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2014.00236","article-title":"Hypothalamic glucose sensing: making ends meet","volume":"8","author":"Routh VH","year":"2014","unstructured":"Routh VH, Hao L, Santiago AM, Sheng Z, Zhou C. Hypothalamic glucose sensing: making ends meet. Front Syst Neurosci. 2014, 8:236. 10.3389\/fnsys.2014.00236","journal-title":"Front Syst Neurosci"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1121\/1.3442572","article-title":"Relationship of blood flow and metabolism to acoustic processing centers of the dolphin brain","volume":"128","author":"Houser DS","year":"2010","unstructured":"Houser DS, Moore PW, Johnson S, et al.. Relationship of blood flow and metabolism to acoustic processing centers of the dolphin brain. J Acoust Soc Am. 2010, 128:1460-6. 10.1121\/1.3442572","journal-title":"J Acoust Soc Am"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.1.105","article-title":"Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract","volume":"50","author":"Cai XJ","year":"2001","unstructured":"Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JR, Wilson S, Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes. 2001, 50:105-12. 10.2337\/diabetes.50.1.105","journal-title":"Diabetes"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1016\/s0031-9384(00)00341-3","article-title":"Effects of leptin and orexin-A on food intake and feeding related hypothalamic neurons","volume":"71","author":"Shiraishi T","year":"2000","unstructured":"Shiraishi T, Oomura Y, Sasaki K, Wayner MJ. Effects of leptin and orexin-A on food intake and feeding related hypothalamic neurons. Physiol Behav. 2000, 71:251-61. 10.1016\/s0031-9384(00)00341-3","journal-title":"Physiol Behav"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1016\/s0303-7207(03)00206-5","article-title":"Orexin-A expression in human peripheral tissues","volume":"205","author":"Nakabayashi M","year":"2003","unstructured":"Nakabayashi M, Suzuki T, Takahashi K, et al.. Orexin-A expression in human peripheral tissues. Mol Cell Endocrinol. 2003, 205:43-50. 10.1016\/s0303-7207(03)00206-5","journal-title":"Mol Cell Endocrinol"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2017.14.301","article-title":"Inverse association of peripheral orexin-A with insulin resistance in type 2 diabetes mellitus: a randomized clinical trial","volume":"14","author":"Zarifkar M","year":"2017","unstructured":"Zarifkar M, Noshad S, Shahriari M, et al.. Inverse association of peripheral orexin-A with insulin resistance in type 2 diabetes mellitus: a randomized clinical trial. Rev Diabet Stud. 2017, 14:301-10. 10.1900\/RDS.2017.14.301","journal-title":"Rev Diabet Stud"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5364-03.2004","article-title":"Hypocretin\/orexin innervation and excitation of identified septohippocampal cholinergic neurons","volume":"24","author":"Wu M","year":"2004","unstructured":"Wu M, Zaborszky L, Hajszan T, van den Pol AN, Alreja M. Hypocretin\/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci. 2004, 24:3527-36. 10.1523\/JNEUROSCI.5364-03.2004","journal-title":"J Neurosci"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.15.6.969","article-title":"Evidence that orexins A and B stimulate insulin secretion from rat pancreatic islets via both receptor subtypes","volume":"15","author":"Nowak KW","year":"2005","unstructured":"Nowak KW, Strowski MZ, Switonska MM, et al.. Evidence that orexins A and B stimulate insulin secretion from rat pancreatic islets via both receptor subtypes. Int J Mol Med. 2005, 15:969-72. 10.3892\/ijmm.15.6.969","journal-title":"Int J Mol Med"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0708","article-title":"Chronotherapeutic effect of orexin antagonists on glucose metabolism in diabetic mice","volume":"243","author":"Kon K","year":"2019","unstructured":"Kon K, Tsuneki H, Ito H, et al.. Chronotherapeutic effect of orexin antagonists on glucose metabolism in diabetic mice. J Endocrinol. 2019, 243:59-72. 10.1530\/JOE-18-0708","journal-title":"J Endocrinol"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.11.2132","article-title":"Hypothalamic orexin expression: modulation by blood glucose and feeding","volume":"48","author":"Cai XJ","year":"1999","unstructured":"Cai XJ, Widdowson P, Harrold J, et al.. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes. 1999, 48:2132-7. 10.2337\/diabetes.48.11.2132","journal-title":"Diabetes"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1016\/s0024-3205(99)00611-6","article-title":"Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies","volume":"66","author":"Nowak KW","year":"2000","unstructured":"Nowak KW, Mackowiak P, Switonska MM, Fabis M, Malendowicz LK. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci. 2000, 66:449-54. 10.1016\/s0024-3205(99)00611-6","journal-title":"Life Sci"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2004.02.004","article-title":"Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat","volume":"119","author":"Ehrstr\u00f6m M","year":"2004","unstructured":"Ehrstr\u00f6m M, N\u00e4slund E, Levin F, Kaur R, Kirchgessner AL, Theodorsson E, Hellstr\u00f6m PM. Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat. Regul Pept. 2004, 119:209-12. 10.1016\/j.regpep.2004.02.004","journal-title":"Regul Pept"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.02.030","article-title":"Acute high-fat diet paradigms link galanin to triglycerides and their transport and metabolism in muscle","volume":"1008","author":"Leibowitz SF","year":"2004","unstructured":"Leibowitz SF, Dourmashkin JT, Chang GQ, Hill JO, Gayles EC, Fried SK, Wang J. Acute high-fat diet paradigms link galanin to triglycerides and their transport and metabolism in muscle. Brain Res. 2004, 1008:168-78. 10.1016\/j.brainres.2004.02.030","journal-title":"Brain Res"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1177\/26320770211050058","article-title":"COVID-19 pandemic and stress: coping with the new normal","volume":"3","author":"Bhattacharjee A","year":"2022","unstructured":"Bhattacharjee A, Ghosh T. COVID-19 pandemic and stress: coping with the new normal. J Prevent Health Promot. 2022, 3:30-52. 10.1177\/26320770211050058","journal-title":"J Prevent Health Promot"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kaab106","article-title":"Psychological predictors of self-reported COVID-19 outcomes: results from a prospective cohort study","volume":"56","author":"Ayling K","year":"2022","unstructured":"Ayling K, Jia R, Coupland C, Chalder T, Massey A, Broadbent E, Vedhara K. Psychological predictors of self-reported COVID-19 outcomes: results from a prospective cohort study. Ann Behav Med. 2022, 56:484-97. 10.1093\/abm\/kaab106","journal-title":"Ann Behav Med"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2020.41","article-title":"COVID-19, mental health and psychological first aid","volume":"37","author":"Minihan E","year":"2020","unstructured":"Minihan E, Gavin B, Kelly BD, McNicholas F. COVID-19, mental health and psychological first aid. Ir J Psychol Med. 2020, 37:259-63. 10.1017\/ipm.2020.41","journal-title":"Ir J Psychol Med"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.23812\/20-EDIT3","article-title":"COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome?","volume":"34","author":"Theoharides TC","year":"2020","unstructured":"Theoharides TC, Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome?. J Biol Regul Homeostat Agents. 2020, 34:1633-6. 10.23812\/20-EDIT3","journal-title":"J Biol Regul Homeostat Agents"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1177\/1073858420941476","article-title":"COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation","volume":"26","author":"Kempuraj D","year":"2020","unstructured":"Kempuraj D, Selvakumar GP, Ahmed ME, et al.. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020, 26:402-14. 10.1177\/1073858420941476","journal-title":"Neuroscientist"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12107","article-title":"Adult neurogenesis and its role in neuropsychiatric disease, brain repair and normal brain function","volume":"40","author":"Braun SM","year":"2014","unstructured":"Braun SM, Jessberger S. Adult neurogenesis and its role in neuropsychiatric disease, brain repair and normal brain function. Neuropathol Appl Neurobiol. 2014, 40:3-12. 10.1111\/nan.12107","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0758-9","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis","volume":"25","author":"Steenblock C","year":"2020","unstructured":"Steenblock C, Todorov V, Kanczkowski W, et al.. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry. 2020, 25:1611-7. 10.1038\/s41380-020-0758-9","journal-title":"Mol Psychiatry"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1327","article-title":"Stress levels of glucocorticoids inhibit LH\u03b2-subunit gene expression in gonadotrope cells","volume":"26","author":"Breen KM","year":"2012","unstructured":"Breen KM, Thackray VG, Hsu T, Mak-McCully RA, Coss D, Mellon PL. Stress levels of glucocorticoids inhibit LH\u03b2-subunit gene expression in gonadotrope cells. Mol Endocrinol. 2012, 26:1716-31. 10.1210\/me.2011-1327","journal-title":"Mol Endocrinol"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.055","article-title":"Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"162","author":"Sakuraba A","year":"2022","unstructured":"Sakuraba A, Luna A, Micic D. Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis. Gastroenterology. 2022, 162:88-108.e9. 10.1053\/j.gastro.2021.09.055","journal-title":"Gastroenterology"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves MD","year":"2021","unstructured":"Taves MD, Ashwell JD. Glucocorticoids in T cell development, differentiation and function. Nat Rev Immunol. 2021, 21:233-43. 10.1038\/s41577-020-00464-0","journal-title":"Nat Rev Immunol"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.01.010","article-title":"Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection","volume":"7","author":"Jamieson AM","year":"2010","unstructured":"Jamieson AM, Yu S, Annicelli CH, Medzhitov R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe. 2010, 7:103-14. 10.1016\/j.chom.2010.01.010","journal-title":"Cell Host Microbe"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1191205","article-title":"Association between glucocorticoids and mortality in patients with severe pneumonia: a systematic review and meta-analysis based on randomized controlled trials","volume":"2022","author":"Tang Q","year":"2022","unstructured":"Tang Q, Chen Q, Li Y, Wang Z. Association between glucocorticoids and mortality in patients with severe pneumonia: a systematic review and meta-analysis based on randomized controlled trials. Comp Mathemat Methods Med. 2022, 2022:1191205. 10.1155\/2022\/1191205","journal-title":"Comp Mathemat Methods Med"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis SC","year":"2011","unstructured":"Meijvis SC, Hardeman H, Remmelts HH, et al.. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011, 377:2023-30. 10.1016\/S0140-6736(11)60607-7","journal-title":"Lancet"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1007\/BF01982624","article-title":"Glucocorticoid induction of angiotensin converting enzyme","volume":"17","author":"Lalenti A","year":"1986","unstructured":"Lalenti A, Calignano A, Carnuccio R, Di Rosa M. Glucocorticoid induction of angiotensin converting enzyme. Agents Actions. 1986, 17:294-5. 10.1007\/BF01982624","journal-title":"Agents Actions"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.9.8366","article-title":"Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress","volume":"142","author":"Armando I","year":"2001","unstructured":"Armando I, Carranza A, Nishimura Y, et al.. Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology. 2001, 142:3880-9. 10.1210\/endo.142.9.8366","journal-title":"Endocrinology"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14439","article-title":"Angiotensin II, a stress-related neuropeptide in the CNS, facilitates micturition reflex in rats","volume":"175","author":"Shimizu S","year":"2018","unstructured":"Shimizu S, Shimizu T, Nakamura K, Higashi Y, Saito M. Angiotensin II, a stress-related neuropeptide in the CNS, facilitates micturition reflex in rats. Br J Pharmacol. 2018, 175:3727-37. 10.1111\/bph.14439","journal-title":"Br J Pharmacol"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.23.1.25","article-title":"Glucocorticoid increases angiotensin II type 1 receptor and its gene expression","volume":"23","author":"Sato A","year":"1994","unstructured":"Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T. Glucocorticoid increases angiotensin II type 1 receptor and its gene expression. Hypertension. 1994, 23:25-30. 10.1161\/01.hyp.23.1.25","journal-title":"Hypertension"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.4223","article-title":"Racial and ethnic disparities in hospitalization outcomes among Medicare beneficiaries during the COVID-19 pandemic","volume":"2","author":"Song Z","year":"2021","unstructured":"Song Z, Zhang X, Patterson LJ, Barnes CL, Haas DA. Racial and ethnic disparities in hospitalization outcomes among Medicare beneficiaries during the COVID-19 pandemic. JAMA Health Forum. 2021, 2:e214223. 10.1001\/jamahealthforum.2021.4223","journal-title":"JAMA Health Forum"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2018.07.026","article-title":"The contribution of orexins to sex differences in the stress response","volume":"1731","author":"Grafe LA","year":"2020","unstructured":"Grafe LA, Bhatnagar S. The contribution of orexins to sex differences in the stress response. Brain Res. 2020, 1731:145893. 10.1016\/j.brainres.2018.07.026","journal-title":"Brain Res"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.2.022305.095305","article-title":"Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome","volume":"2","author":"Keane TM","year":"2006","unstructured":"Keane TM, Marshall AD, Taft CT. Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Ann Rev Clin Psychol. 2006, 2:161-97. 10.1146\/annurev.clinpsy.2.022305.095305","journal-title":"Ann Rev Clin Psychol"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-0030","article-title":"Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors","volume":"144","author":"Johren O","year":"2003","unstructured":"Johren O, Bruggemann N, Dendorfer A, Dominiak P. Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors. Endocrinology. 2003, 144:1219-25. 10.1210\/en.2002-0030","journal-title":"Endocrinology"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.8.8299","article-title":"Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats","volume":"142","author":"Johren O","year":"2001","unstructured":"Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology. 2001, 142:3324-31. 10.1210\/endo.142.8.8299","journal-title":"Endocrinology"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-0115(01)00359-7","article-title":"Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas","volume":"104","author":"Blanco M","year":"2002","unstructured":"Blanco M, Garcia-Caballero T, Fraga M, et al.. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul Pept. 2002, 104:161-5. 10.1016\/s0167-0115(01)00359-7","journal-title":"Regul Pept"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2005.05.003","article-title":"Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor","volume":"96","author":"Ziolkowska A","year":"2005","unstructured":"Ziolkowska A, Spinazzi R, Albertin G, et al.. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor. J Steroid Biochem Mol Biol. 2005, 96:423-9. 10.1016\/j.jsbmb.2005.05.003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1385\/MN:32:3:285","article-title":"Stress and arousal: the corticotrophin-releasing factor\/hypocretin circuitry","volume":"32","author":"Winsky-Sommerer R","year":"2005","unstructured":"Winsky-Sommerer R, Boutrel B, de Lecea L. Stress and arousal: the corticotrophin-releasing factor\/hypocretin circuitry. Mol Neurobiol. 2005, 32:285-94. 10.1385\/MN:32:3:285","journal-title":"Mol Neurobiol"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2412","article-title":"Possible involvement of orexin in the stress reaction in rats","volume":"270","author":"Ida T","year":"2000","unstructured":"Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun. 2000, 270:318-23. 10.1006\/bbrc.2000.2412","journal-title":"Biochem Biophys Res Commun"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.2001.00654.x","article-title":"The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation","volume":"13","author":"Jaszberenyi M","year":"2001","unstructured":"Jaszberenyi M, Bujdoso E, Telegdy G. The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation. J Neuroendocrinol. 2001, 13:438-41. 10.1046\/j.1365-2826.2001.00654.x","journal-title":"J Neuroendocrinol"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00671.2002","article-title":"Attenuated defense response and low basal blood pressure in orexin knockout mice","volume":"285","author":"Kayaba Y","year":"2003","unstructured":"Kayaba Y, Nakamura A, Kasuya Y, et al.. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol. 2003, 285:581-93. 10.1152\/ajpregu.00671.2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref206","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3138-09.2009","article-title":"Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins","volume":"29","author":"Rachalski A","year":"2009","unstructured":"Rachalski A, Alexandre C, Bernard JF, et al.. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci. 2009, 29:15575-85. 10.1523\/JNEUROSCI.3138-09.2009","journal-title":"J Neurosci"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2009.09.019","article-title":"Hypocretin\/orexin in arousal and stress","volume":"1314","author":"Berridge CW","year":"2010","unstructured":"Berridge CW, Espana RA, Vittoz NM. Hypocretin\/orexin in arousal and stress. Brain Res. 2010, 1314:91-102. 10.1016\/j.brainres.2009.09.019","journal-title":"Brain Res"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2010.195099","article-title":"Orexin neurons are indispensable for stress-induced thermogenesis in mice","volume":"588","author":"Zhang W","year":"2010","unstructured":"Zhang W, Sunanaga J, Takahashi Y, Mori T, Sakurai T, Kanmura Y, Kuwaki T. Orexin neurons are indispensable for stress-induced thermogenesis in mice. J Physiol. 2010, 588:4117-29. 10.1113\/jphysiol.2010.195099","journal-title":"J Physiol"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26000","article-title":"Update on the neurology of COVID-19","volume":"92","author":"Finisterer J","year":"2020","unstructured":"Finisterer J, Stollberger C. Update on the neurology of COVID-19. J Med Virol. 2020, 92:2316-8. 10.1002\/jmv.26000","journal-title":"J Med Virol"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.10.021","article-title":"Orexin A regulates cardiovascular responses in stress-induced hypertensive rats","volume":"67","author":"Xiao F","year":"2012","unstructured":"Xiao F, Jiang M, Du D, et al.. Orexin A regulates cardiovascular responses in stress-induced hypertensive rats. Neuropharmacology. 2012, 67:16-24. 10.1016\/j.neuropharm.2012.10.021","journal-title":"Neuropharmacology"},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01694.x","article-title":"Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex","volume":"165","author":"Shahid IZ","year":"2012","unstructured":"Shahid IZ, Rahman AA, Pilowsky PM. Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex. Br J Pharmacol. 2012, 165:2292-303. 10.1111\/j.1476-5381.2011.01694.x","journal-title":"Br J Pharmacol"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.07053","article-title":"Contribution of orexin to the neurogenic hypertension in BPH\/2J mice","volume":"67","author":"Jackson KL","year":"2016","unstructured":"Jackson KL, Dampney BW, Moretti JL, Stevenson ER, Davern PJ, Carrive P, Head GA. Contribution of orexin to the neurogenic hypertension in BPH\/2J mice. Hypertension. 2016, 67:959-69. 10.1161\/HYPERTENSIONAHA.115.07053","journal-title":"Hypertension"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.1113\/EP085016","article-title":"Spontaneously hypertensive rats have more orexin neurons in the hypothalamus and enhanced orexinergic input and orexin 2 receptor-associated nitric oxide signalling in the rostral ventrolateral medulla","volume":"100","author":"Lee YH","year":"2015","unstructured":"Lee YH, Tsai MC, Li TL, Dai YW, Huang SC, Hwang LL. Spontaneously hypertensive rats have more orexin neurons in the hypothalamus and enhanced orexinergic input and orexin 2 receptor-associated nitric oxide signalling in the rostral ventrolateral medulla. Exp Physiol. 2015, 100:993-1007. 10.1113\/EP085016","journal-title":"Exp Physiol"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.281.6.R1801","article-title":"Orexins\/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro","volume":"281","author":"Antunes VR","year":"2001","unstructured":"Antunes VR, Brailoiu GC, Kwok EH, Scruggs P, Dun NJ. Orexins\/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am J Physiol Regul Integr Comp Physiol. 2001, 281:R1801-7. 10.1152\/ajpregu.2001.281.6.R1801","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12963","article-title":"Orexin A increases sympathetic nerve activity through promoting expression of proinflammatory cytokines in Sprague Dawley rats","volume":"222","author":"Fan Y","year":"2018","unstructured":"Fan Y, Jiang E, Hahka T, Chen QH, Yan J, Shan Z. Orexin A increases sympathetic nerve activity through promoting expression of proinflammatory cytokines in Sprague Dawley rats. Acta Physiol (Oxf). 2018, 222:e13011. 10.1111\/apha.12963","journal-title":"Acta Physiol (Oxf)"},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2006.11.009","article-title":"Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats","volume":"57","author":"Chang H","year":"2007","unstructured":"Chang H, Saito T, Ohiwa N, Tateoka M, Deocaris CC, Fujikawa T, Soya H. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats. Neurosci Res. 2007, 57:462-6. 10.1016\/j.neures.2006.11.009","journal-title":"Neurosci Res"},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35115","article-title":"Hypocretin\/orexin and nociceptin\/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia","volume":"118","author":"Xie X","year":"2008","unstructured":"Xie X, Wisor JP, Hara J, et al.. Hypocretin\/orexin and nociceptin\/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. J Clin Invest. 2008, 118:2471-81. 10.1172\/JCI35115","journal-title":"J Clin Invest"},{"key":"ref218","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.12.026","article-title":"Direct inhibition of hypocretin\/orexin neurons in the lateral hypothalamus by nociceptin\/orphanin FQ blocks stress-induced analgesia in rats","volume":"60","author":"Gerashchenko D","year":"2011","unstructured":"Gerashchenko D, Horvath TL, Xie XS. Direct inhibition of hypocretin\/orexin neurons in the lateral hypothalamus by nociceptin\/orphanin FQ blocks stress-induced analgesia in rats. Neuropharmacology. 2011, 60:543-9. 10.1016\/j.neuropharm.2010.12.026","journal-title":"Neuropharmacology"},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200501190-00002","article-title":"Persistent pain and stress activate pain-inhibitory orexin pathways","volume":"16","author":"Watanabe S","year":"2005","unstructured":"Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport. 2005, 16:5-8. 10.1097\/00001756-200501190-00002","journal-title":"Neuroreport"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.01.010","article-title":"High pain frequency in narcolepsy with cataplexy","volume":"12","author":"Dauvilliers Y","year":"2011","unstructured":"Dauvilliers Y, Bayard S, Shneerson JM, Plazzi G, Myers AJ, Garcia-Borreguero D. High pain frequency in narcolepsy with cataplexy. Sleep Med. 2011, 12:572-7. 10.1016\/j.sleep.2011.01.010","journal-title":"Sleep Med"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.1177\/1470320313503694","article-title":"Renin-angiotensin system in pain: existing in a double life?","volume":"15","author":"Bali A","year":"2014","unstructured":"Bali A, Singh N, Jaggi AS. Renin-angiotensin system in pain: existing in a double life?. J Renin Angiotensin Aldosterone Syst. 2014, 15:329-40. 10.1177\/1470320313503694","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.1038\/srep29480","article-title":"The integrative role of orexin\/hypocretin neurons in nociceptive perception and analgesic regulation","volume":"6","author":"Inutsuka A","year":"2016","unstructured":"Inutsuka A, Yamashita A, Chowdhury S, Nakai J, Ohkura M, Taguchi T, Yamanaka A. The integrative role of orexin\/hypocretin neurons in nociceptive perception and analgesic regulation. Sci Rep. 2016, 6:29480. 10.1038\/srep29480","journal-title":"Sci Rep"},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1","article-title":"The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding","volume":"62","author":"Sutcliffe JG","year":"2000","unstructured":"Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res. 2000, 62:161-8. 10.1002\/1097-4547(20001015)62:2&lt;161::AID-JNR1&gt;3.0.CO;2-1","journal-title":"J Neurosci Res"},{"key":"ref224","article-title":"Orexin A but not orexin B rapidly enters brain from blood by simple diffusion","volume":"289","author":"Kastin AJ","year":"1999","unstructured":"Kastin AJ, Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther. 1999, 289:219-23.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref225","article-title":"Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22","volume":"55","author":"Wilhelmsen KC","year":"1994","unstructured":"Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet. 1994, 55:1159-65.","journal-title":"Am J Hum Genet"},{"key":"ref226","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104754","article-title":"Orexin and Parkinson's disease: a protective neuropeptide with therapeutic potential","volume":"138","author":"Liu C","year":"2020","unstructured":"Liu C, Xue Y, Liu MF, Wang Y, Chen L. Orexin and Parkinson's disease: a protective neuropeptide with therapeutic potential. Neurochem Int. 2020, 138:104754. 10.1016\/j.neuint.2020.104754","journal-title":"Neurochem Int"},{"key":"ref227","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-010-0410-9","article-title":"Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease","volume":"26","author":"Cui LB","year":"2010","unstructured":"Cui LB, Li BW, Jin XH, Zhao L, Shi J. Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease. Neurosci Bull. 2010, 26:381-7. 10.1007\/s12264-010-0410-9","journal-title":"Neurosci Bull"},{"key":"ref228","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2018.08.004","article-title":"Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model","volume":"309","author":"Oliveira LM","year":"2018","unstructured":"Oliveira LM, Falquetto B, Moreira TS, Takakura AC. Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model. Exp Neurol. 2018, 309:107-18. 10.1016\/j.expneurol.2018.08.004","journal-title":"Exp Neurol"},{"key":"ref229","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal TC","year":"2007","unstructured":"Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain. 2007, 130:1586-95. 10.1093\/brain\/awm097","journal-title":"Brain"},{"key":"ref230","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek R","year":"2007","unstructured":"Fronczek R, Overeem S, Lee SY, et al.. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007, 130:1577-85. 10.1093\/brain\/awm090","journal-title":"Brain"},{"key":"ref231","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00702","article-title":"Chemogenetic modulation of orexin neurons reverses changes in anxiety and locomotor activity in the A53T mouse model of Parkinson's disease","volume":"13","author":"Stanojlovic M","year":"2019","unstructured":"Stanojlovic M, Pallais JP, Kotz CM. Chemogenetic modulation of orexin neurons reverses changes in anxiety and locomotor activity in the A53T mouse model of Parkinson's disease. Front Neurosci. 2019, 13:702. 10.3389\/fnins.2019.00702","journal-title":"Front Neurosci"},{"key":"ref232","doi-asserted-by":"publisher","DOI":"10.1113\/EP087507","article-title":"Respiratory disturbances in a mouse model of Parkinson's disease","volume":"104","author":"Oliveira LM","year":"2019","unstructured":"Oliveira LM, Oliveira MA, Moriya HT, Moreira TS, Takakura AC. Respiratory disturbances in a mouse model of Parkinson's disease. Exp Physiol. 2019, 104:729-39. 10.1113\/EP087507","journal-title":"Exp Physiol"},{"key":"ref233","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.4.1060","article-title":"Plasma orexin-A levels and body composition in COPD","volume":"123","author":"Matsumura T","year":"2003","unstructured":"Matsumura T, Nakayama M, Satoh H, Naito A, Kamahara K, Sekizawa K. Plasma orexin-A levels and body composition in COPD. Chest. 2003, 123:1060-5. 10.1378\/chest.123.4.1060","journal-title":"Chest"},{"key":"ref234","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/754847","article-title":"Plasma orexin-A levels in COPD patients with hypercapnic respiratory failure","volume":"2011","author":"Zhu LY","year":"2011","unstructured":"Zhu LY, Summah H, Jiang HN, Qu JM. Plasma orexin-A levels in COPD patients with hypercapnic respiratory failure. Mediators Inflamm. 2011, 2011:754847. 10.1155\/2011\/754847","journal-title":"Mediators Inflamm"},{"key":"ref235","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (orexin) loss in Alzheimer's disease","volume":"33","author":"Fronczek R","year":"2012","unstructured":"Fronczek R, van Geest S, Fr\u00f6lich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging. 2012, 33:1642-50. 10.1016\/j.neurobiolaging.2011.03.014","journal-title":"Neurobiol Aging"},{"key":"ref236","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.5846","article-title":"Orexin-A is associated with increases in cerebrospinal fluid phosphorylated-tau in cognitively normal elderly subjects","volume":"39","author":"Osorio RS","year":"2016","unstructured":"Osorio RS, Ducca EL, Wohlleber ME, et al.. Orexin-A is associated with increases in cerebrospinal fluid phosphorylated-tau in cognitively normal elderly subjects. Sleep. 2016, 39:1253-60. 10.5665\/sleep.5846","journal-title":"Sleep"},{"key":"ref237","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.01.031","article-title":"Age-related loss of orexin\/hypocretin neurons","volume":"178","author":"Kessler BA","year":"2011","unstructured":"Kessler BA, Stanley EM, Frederick-Duus D, Fadel JR. Age-related loss of orexin\/hypocretin neurons. Neuroscience. 2011, 178:82-8. 10.1016\/j.neuroscience.2011.01.031","journal-title":"Neuroscience"},{"key":"ref238","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.05.073","article-title":"Orexin-1 receptor is involved in ageing-related delayed emergence from general anaesthesia in rats","volume":"121","author":"Ran M","year":"2018","unstructured":"Ran M, Wang Z, Yang H, et al.. Orexin-1 receptor is involved in ageing-related delayed emergence from general anaesthesia in rats. Br J Anaesth. 2018, 121:1097-104. 10.1016\/j.bja.2018.05.073","journal-title":"Br J Anaesth"},{"key":"ref239","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(01)02476-4","article-title":"Plasma orexin-A is lower in patients with narcolepsy","volume":"318","author":"Higuchi S","year":"2002","unstructured":"Higuchi S, Usui A, Murasaki M, et al.. Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett. 2002, 318:61-4. 10.1016\/s0304-3940(01)02476-4","journal-title":"Neurosci Lett"},{"key":"ref240","doi-asserted-by":"publisher","DOI":"10.1016\/s0531-5565(02)00092-x","article-title":"Age-related changes in plasma orexin-A concentrations","volume":"37","author":"Matsumura T","year":"2002","unstructured":"Matsumura T, Nakayama M, Nomura A, et al.. Age-related changes in plasma orexin-A concentrations. Exp Gerontol. 2002, 37:1127-30. 10.1016\/s0531-5565(02)00092-x","journal-title":"Exp Gerontol"},{"key":"ref241","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2016_49","article-title":"Orexin\/hypocretin signaling","volume":"33","author":"Kukkonen JP","year":"2017","unstructured":"Kukkonen JP. Orexin\/hypocretin signaling. Curr Top Behav Neurosci. 2017, 33:17-50. 10.1007\/7854_2016_49","journal-title":"Curr Top Behav Neurosci"},{"key":"ref242","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2018.11.008","article-title":"High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss","volume":"157","author":"Duffy CM","year":"2019","unstructured":"Duffy CM, Hofmeister JJ, Nixon JP, Butterick TA. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss. Neurobiol Learn Mem. 2019, 157:41-7. 10.1016\/j.nlm.2018.11.008","journal-title":"Neurobiol Learn Mem"},{"key":"ref243","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00927.2005","article-title":"Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal","volume":"95","author":"Huang H","year":"2006","unstructured":"Huang H, Ghosh P, van den Pol AN. Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J Neurophysiol. 2006, 95:1656-68. 10.1152\/jn.00927.2005","journal-title":"J Neurophysiol"},{"key":"ref244","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.05.038","article-title":"Orexin-A excites pyramidal neurons in layer 2\/3 of the rat prefrontal cortex","volume":"520","author":"Yan J","year":"2012","unstructured":"Yan J, He C, Xia JX, Zhang D, Hu ZA. Orexin-A excites pyramidal neurons in layer 2\/3 of the rat prefrontal cortex. Neurosci Lett. 2012, 520:92-7. 10.1016\/j.neulet.2012.05.038","journal-title":"Neurosci Lett"},{"key":"ref245","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(02)00745-5","article-title":"Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-Schaffer collateral long-term potentiation in rats","volume":"119","author":"Aou S","year":"2003","unstructured":"Aou S, Li XL, Li AJ, et al.. Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-Schaffer collateral long-term potentiation in rats. Neuroscience. 2003, 119:1221-8. 10.1016\/s0306-4522(02)00745-5","journal-title":"Neuroscience"},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.1.99","article-title":"Decision making in narcolepsy with cataplexy","volume":"34","author":"Bayard S","year":"2011","unstructured":"Bayard S, Abril B, Yu H, Scholz S, Carlander B, Dauvilliers Y. Decision making in narcolepsy with cataplexy. Sleep. 2011, 34:99-104. 10.1093\/sleep\/34.1.99","journal-title":"Sleep"},{"key":"ref247","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0719-05.2005","article-title":"Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat","volume":"25","author":"Lambe EK","year":"2005","unstructured":"Lambe EK, Olausson P, Horst NK, Taylor JR, Aghajanian GK. Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J Neurosci. 2005, 25:5225-9. 10.1523\/JNEUROSCI.0719-05.2005","journal-title":"J Neurosci"},{"key":"ref248","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3878-07.2007","article-title":"Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates","volume":"27","author":"Deadwyler SA","year":"2007","unstructured":"Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci. 2007, 27:14239-47. 10.1523\/JNEUROSCI.3878-07.2007","journal-title":"J Neurosci"},{"key":"ref249","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3301-08.2008","article-title":"Memory enhancement with event-related stimulation of the rostral intralaminar thalamic nuclei","volume":"28","author":"Mair RG","year":"2008","unstructured":"Mair RG, Hembrook JR. Memory enhancement with event-related stimulation of the rostral intralaminar thalamic nuclei. J Neurosci. 2008, 28:14293-300. 10.1523\/JNEUROSCI.3301-08.2008","journal-title":"J Neurosci"},{"key":"ref250","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2007.09.019","article-title":"The effect of antagonization of orexin 1 receptors in CA1 and dentate gyrus regions on memory processing in passive avoidance task","volume":"187","author":"Akbari E","year":"2008","unstructured":"Akbari E, Motamedi F, Naghdi N, Noorbakhshnia M. The effect of antagonization of orexin 1 receptors in CA1 and dentate gyrus regions on memory processing in passive avoidance task. Behav Brain Res. 2008, 187:172-7. 10.1016\/j.bbr.2007.09.019","journal-title":"Behav Brain Res"},{"key":"ref251","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2011.01.021","article-title":"SB-334867-A, a selective orexin-1 receptor antagonist, enhances taste aversion learning and blocks taste preference learning in rats","volume":"98","author":"Mediavilla C","year":"2011","unstructured":"Mediavilla C, Cabello V, Risco S. SB-334867-A, a selective orexin-1 receptor antagonist, enhances taste aversion learning and blocks taste preference learning in rats. Pharmacol Biochem Behav. 2011, 98:385-91. 10.1016\/j.pbb.2011.01.021","journal-title":"Pharmacol Biochem Behav"},{"key":"ref252","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1933-5","article-title":"Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant","volume":"212","author":"Dietrich H","year":"2010","unstructured":"Dietrich H, Jenck F. Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant. Psychopharmacology. 2010, 212:145-54. 10.1007\/s00213-010-1933-5","journal-title":"Psychopharmacology"},{"key":"ref253","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0127-0","article-title":"Orexin prevents depressive-like behavior by promoting stress resilience","volume":"24","author":"Ji MJ","year":"2019","unstructured":"Ji MJ, Zhang XY, Chen Z, Wang JJ, Zhu JN. Orexin prevents depressive-like behavior by promoting stress resilience. Mol Psychiatry. 2019, 24:282-93. 10.1038\/s41380-018-0127-0","journal-title":"Mol Psychiatry"},{"key":"ref254","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S209023","article-title":"Reduced plasma orexin-A levels in patients with bipolar disorder","volume":"15","author":"Tsuchimine S","year":"2019","unstructured":"Tsuchimine S, Hattori K, Ota M, et al.. Reduced plasma orexin-A levels in patients with bipolar disorder. Neuropsychiatr Dis Treat. 2019, 15:2221-30. 10.2147\/NDT.S209023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref255","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200006260-00034","article-title":"Centrally administered orexin\/hypocretin activates HPA axis in rats","volume":"11","author":"Kuru M","year":"2000","unstructured":"Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, Shibuya I, Yamashita H. Centrally administered orexin\/hypocretin activates HPA axis in rats. Neuroreport. 2000, 11:1977-80. 10.1097\/00001756-200006260-00034","journal-title":"Neuroreport"},{"key":"ref256","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.07.018","article-title":"Excitatory action of hypocretin\/orexin on neurons of the central medial amygdala","volume":"142","author":"Bisetti A","year":"2006","unstructured":"Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, Jones BE, M\u00fchlethaler M. Excitatory action of hypocretin\/orexin on neurons of the central medial amygdala. Neuroscience. 2006, 142:999-1004. 10.1016\/j.neuroscience.2006.07.018","journal-title":"Neuroscience"},{"key":"ref257","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2075","article-title":"A key role for orexin in panic anxiety","volume":"16","author":"Johnson PL","year":"2010","unstructured":"Johnson PL, Truitt W, Fitz SD, et al.. A key role for orexin in panic anxiety. Nat Med. 2010, 16:111-5. 10.1038\/nm.2075","journal-title":"Nat Med"},{"key":"ref258","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.12.012","article-title":"Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms","volume":"53","author":"Chien YL","year":"2015","unstructured":"Chien YL, Liu CM, Shan JC, Lee HJ, Hsieh MH, Hwu HG, Chiou LC. Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms. Psychoneuroendocrinology. 2015, 53:1-9. 10.1016\/j.psyneuen.2014.12.012","journal-title":"Psychoneuroendocrinology"},{"key":"ref259","doi-asserted-by":"publisher","DOI":"10.3389.fpsyt.2022.879414","article-title":"Plasma orexin-A levels in patients with schizophrenia: a systematic review and meta-analysis","volume":"13","author":"Li S","year":"2022","unstructured":"Li S, Zhang R, Hu S, Lai J. Plasma orexin-A levels in patients with schizophrenia: a systematic review and meta-analysis. Front Psychiatr. 2022, 13:879414. 10.3389.fpsyt.2022.879414","journal-title":"Front Psychiatr"},{"key":"ref260","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3959(00)00470-x","article-title":"Orexin-A, an hypothalamic peptide with analgesic properties","volume":"92","author":"Bingham S","year":"2001","unstructured":"Bingham S, Davey PT, Babbs AJ, et al.. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001, 92:81-90. 10.1016\/s0304-3959(00)00470-x","journal-title":"Pain"},{"key":"ref261","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.01.001","article-title":"Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice","volume":"26","author":"Mobarakeh JI","year":"2005","unstructured":"Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Yanai K. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides. 2005, 26:767-77. 10.1016\/j.peptides.2005.01.001","journal-title":"Peptides"},{"key":"ref262","doi-asserted-by":"publisher","DOI":"10.1080\/23328940.2015.1066921","article-title":"Thermoregulation under pressure: a role for orexin neurons","volume":"2","author":"Kuwaki T","year":"2015","unstructured":"Kuwaki T. Thermoregulation under pressure: a role for orexin neurons. Temperature. 2015, 2:379-91. 10.1080\/23328940.2015.1066921","journal-title":"Temperature"},{"key":"ref263","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00919.2007","article-title":"Ventilatory long-term facilitation in mice can be observed during both sleep and wake periods and depends on orexin","volume":"104","author":"Terada J","year":"2008","unstructured":"Terada J, Nakamura A, Zhang W, Yanagisawa M, Kuriyama T, Fukuda Y, Kuwaki T. Ventilatory long-term facilitation in mice can be observed during both sleep and wake periods and depends on orexin. J Appl Physiol. 2008, 104:499-507. 10.1152\/japplphysiol.00919.2007","journal-title":"J Appl Physiol"},{"key":"ref264","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2007.06.004","article-title":"Activation of orexin B receptors in the pontine Kolliker-Fuse nucleus modulates pre-inspiratory hypoglossal motor activity in rat","volume":"159","author":"Dutschmann M","year":"2007","unstructured":"Dutschmann M, Kron M, Morschel M, Gestreau C. Activation of orexin B receptors in the pontine Kolliker-Fuse nucleus modulates pre-inspiratory hypoglossal motor activity in rat. Respir Physiol Neurobiol. 2007, 159:232-5. 10.1016\/j.resp.2007.06.004","journal-title":"Respir Physiol Neurobiol"},{"key":"ref265","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01102.x","article-title":"Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex","volume":"162","author":"Shahid IZ","year":"2011","unstructured":"Shahid IZ, Rahman AA, Pilowsky PM. Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex. Br J Pharmacol. 2011, 162:961-73. 10.1111\/j.1476-5381.2010.01102.x","journal-title":"Br J Pharmacol"},{"key":"ref266","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2010.05411.x","article-title":"Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease","volume":"37","author":"Liu ZB","year":"2010","unstructured":"Liu ZB, Song NN, Geng WY, et al.. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol. 2010, 37:963-8. 10.1111\/j.1440-1681.2010.05411.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref267","doi-asserted-by":"publisher","DOI":"10.1111\/J.1479-8425.2010.00467.X","article-title":"Narcolepsy, orexins and respiratory regulation","volume":"9","author":"Han F","year":"2012","unstructured":"Han F. Narcolepsy, orexins and respiratory regulation. Sleep Biological Rhythm. 2012, 9:44-51. 10.1111\/J.1479-8425.2010.00467.X","journal-title":"Sleep Biological Rhythm"},{"key":"ref268","doi-asserted-by":"publisher","DOI":"10.1159\/000081757","article-title":"Decreased plasma levels of orexin-A in sleep apnea","volume":"71","author":"Busquets X","year":"2004","unstructured":"Busquets X, Barbe F, Barcelo A, et al.. Decreased plasma levels of orexin-A in sleep apnea. Respiration. 2004, 71:575-9. 10.1159\/000081757","journal-title":"Respiration"},{"key":"ref269","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20161493","article-title":"Orexin receptors: a journey through their discovery to the development of suvorexant, the new sleeping pill","volume":"5","author":"Nishanthi A","year":"2016","unstructured":"Nishanthi A, Vimal M, Sandhiya S, Dkhar S. Orexin receptors: a journey through their discovery to the development of suvorexant, the new sleeping pill. IJBCP. 2016, 5:573-8. 10.18203\/2319-2003.ijbcp20161493","journal-title":"IJBCP"},{"key":"ref270","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0553-z","article-title":"The selective orexin-2 antagonist seltorexant (JNJ-42847922\/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder","volume":"9","author":"Recourt K","year":"2019","unstructured":"Recourt K, de Boer P, Zuiker R, et al.. The selective orexin-2 antagonist seltorexant (JNJ-42847922\/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Transl Psychiatry. 2019, 9:216. 10.1038\/s41398-019-0553-z","journal-title":"Transl Psychiatry"},{"key":"ref271","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25680","article-title":"Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder","volume":"87","author":"Dauvilliers Y","year":"2020","unstructured":"Dauvilliers Y, Zammit G, Fietze I, Mayleben D, Seboek Kinter D, Pain S, Hedner J. Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder. Ann Neurol. 2020, 87:347-56. 10.1002\/ana.25680","journal-title":"Ann Neurol"},{"key":"ref272","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1817380","article-title":"Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders","volume":"16","author":"Muehlan C","year":"2020","unstructured":"Muehlan C, Vaillant C, Zenklusen I, Kraehenbuehl S, Dingemanse J. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders. Expert Opin Drug Metab Toxicol. 2020, 16:1063-78. 10.1080\/17425255.2020.1817380","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref273","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2020.0136","article-title":"Orexin and Alzheimer's disease: a new perspective","volume":"17","author":"Um YH","year":"2020","unstructured":"Um YH, Lim HK. Orexin and Alzheimer's disease: a new perspective. Psychiatry Investig. 2020, 17:621-6. 10.30773\/pi.2020.0136","journal-title":"Psychiatry Investig"},{"key":"ref274","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.09.004","article-title":"Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis","volume":"35","author":"Kuriyama A","year":"2017","unstructured":"Kuriyama A, Tabata H. Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis. Sleep Med Rev. 2017, 35:1-7. 10.1016\/j.smrv.2016.09.004","journal-title":"Sleep Med Rev"},{"key":"ref275","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-019-00447-9","article-title":"Orexin receptor antagonists as emerging treatments for psychiatric disorders","volume":"36","author":"Han Y","year":"2020","unstructured":"Han Y, Yuan K, Zheng Y, Lu L. Orexin receptor antagonists as emerging treatments for psychiatric disorders. Neurosci Bull. 2020, 36:432-48. 10.1007\/s12264-019-00447-9","journal-title":"Neurosci Bull"},{"key":"ref276","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00163","article-title":"Orexin receptor antagonists as therapeutic agents for insomnia","volume":"4","author":"Equihua AC","year":"2013","unstructured":"Equihua AC, De La Herran-Arita AK, Drucker-Colin R. Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol. 2013, 4:163. 10.3389\/fphar.2013.00163","journal-title":"Front Pharmacol"},{"key":"ref277","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0064-z","article-title":"Role of orexin in the pathophysiology of depression: potential for pharmacological intervention","volume":"276","author":"Nollet M","year":"2013","unstructured":"Nollet M, Leman S. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention. CNS Drugs. 2013, 276:411-22. 10.1007\/s40263-013-0064-z","journal-title":"CNS Drugs"},{"key":"ref278","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin-angiotensin\u2014a new look at an old system","volume":"95","author":"Wright JW","year":"2011","unstructured":"Wright JW, Harding JW. Brain renin-angiotensin\u2014a new look at an old system. Prog Neurobiol. 2011, 95:49-67. 10.1016\/j.pneurobio.2011.07.001","journal-title":"Prog Neurobiol"},{"key":"ref279","doi-asserted-by":"publisher","DOI":"10.2174\/0929866527666191223143230","article-title":"Neuropsychiatric properties of the ACE2\/Ang-(1-7)\/Mas pathway: a brief review","volume":"27","author":"De Melo LA","year":"2020","unstructured":"De Melo LA, Almeida-Santos AF. Neuropsychiatric properties of the ACE2\/Ang-(1-7)\/Mas pathway: a brief review. Protein Pept Lett. 2020, 27:476-83. 10.2174\/0929866527666191223143230","journal-title":"Protein Pept Lett"},{"key":"ref280","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12249","article-title":"SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats","volume":"31","author":"Kordi Jaz E","year":"2017","unstructured":"Kordi Jaz E, Moghimi A, Fereidoni M, Asadi S, Shamsizadeh A, Roohbakhsh A. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats. Fundam Clin Pharmacol. 2017, 31:201-7. 10.1111\/fcp.12249","journal-title":"Fundam Clin Pharmacol"},{"key":"ref281","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12636","article-title":"Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives","volume":"35","author":"Courault P","year":"2021","unstructured":"Courault P, Demarquay G, Zimmer L, Lancelot S. Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives. Clin Pharmacol. 2021, 35:595-619. 10.1111\/fcp.12636","journal-title":"Clin Pharmacol"},{"key":"ref282","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180150","article-title":"Functional cardiac orexin receptors: role of orexin-B\/orexin 2 receptor in myocardial protection","volume":"132","author":"Patel VH","year":"2018","unstructured":"Patel VH, Karteris E, Chen J, et al.. Functional cardiac orexin receptors: role of orexin-B\/orexin 2 receptor in myocardial protection. Clin Sci (Lond). 2018, 132:2547-64. 10.1042\/CS20180150","journal-title":"Clin Sci (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119037-a-bitter-experience-that-enlightens-the-future-covid-19-neurological-affection-and-perspectives-on-the-orexigenic-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:48Z","timestamp":1707507768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119037-a-bitter-experience-that-enlightens-the-future-covid-19-neurological-affection-and-perspectives-on-the-orexigenic-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":282,"URL":"https:\/\/doi.org\/10.7759\/cureus.30788","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}